Giá của ViewRay, Inc. là bao nhiêu (VRAY)

Giá của ViewRay, Inc. (VRAY) là $0.014

Mũ thị trường của ViewRay, Inc. là gì (VRAY)

Giới hạn thị trường của ViewRay, Inc. (VRAY) là $2.07M

Lịch sử giá ViewRay, Inc. (VRAY)

ViewRay, Inc. specializes in the development, production, and global distribution of advanced radiation therapy systems that leverage magnetic resonance imaging (MRI). These integrated systems are utilized to both image and deliver treatment for cancer patients in various countries, including the United States, France, Taiwan, and the United Kingdom. The company's key product, MRIdian, is an MRI-guided radiation therapy solution engineered to address critical concerns during treatment, such as beam distortion and potential skin toxicity. ViewRay's client base spans a diverse range of medical facilities, including university research and teaching hospitals, local community hospitals, private medical practices, government institutions, and independent cancer treatment centers. MRIdian systems are sold to these clients via ViewRay's direct sales force and through its established distribution channels. The company was founded in 2004 and operates out of its main office in Oakwood, Ohio.

Năm	Hiệu suất
2023	-99.70%
2022	-13.86%
2021	33.62%
2020	-7.02%
2019	-28.31%
2018	-34.19%
2017	168.70%
2016	-29.83%
2015	0.00%

Năm

Hiệu suất

2023

-99.70%

2022

-13.86%

2021

33.62%

2020

-7.02%

2019

-28.31%

2018

-34.19%

2017

168.70%

2016

-29.83%

2015

0.00%

Công ty	Giá cổ phiếu	Thay đổi 1năm%	Quốc gia
Abbott Laboratories ABT.US	$111.15	-15.64%	US
Stryker Corporation SYK.US	$339.00	-11.24%	US
Medtronic plc MDT.US	$91.19	-1.97%	IE
Boston Scientific Corporation BSX.US	$51.77	-49.83%	US
Edwards Lifesciences Corporation EW.US	$91.49	16.90%	US

Công ty

Giá cổ phiếu

Thay đổi 1năm%

Quốc gia